chromosomal abnormalities

Related by string. Chromosomal abnormalities * Chromosomal : chromosomal rearrangements . chromosomal aberrations . chromosomal instability . both genders chromosomal . chromosomal rearrangement / Abnormalities : rhythm abnormalities . chromosome abnormalities . additional cytogenetic abnormalities . fetal abnormalities . congenital abnormalities * fetal chromosomal abnormalities *

Related by context. All words. (Click for frequent words.) 76 genetic abnormalities 72 chromosome abnormalities 72 aneuploidies 70 aneuploidy 68 abnormalities 68 chromosomal disorders 67 genetic defects 66 gene mutations 66 congenital anomalies 66 chromosomal anomalies 65 mosaicism 65 inherited mutations 64 neural tube defect 64 recurrent miscarriages 64 genetic abnormality 64 genetic mutations 64 microdeletions 64 mutations 64 developmental abnormalities 64 endometrial cancers 64 trisomy 63 congenital abnormalities 63 BRCA2 gene 63 chromosome abnormality 63 congenital malformations 62 abnormal chromosomes 62 chromosomal aberrations 62 BRCA1 mutations 62 chromosomal alterations 62 ovarian tumors 62 unexplained infertility 62 somatic mutations 62 chromosomal defect 62 genetic syndromes 62 microdeletion 62 familial ALS 62 chromosomal instability 62 preterm deliveries 62 mitochondrial dysfunction 61 gene variants 61 sporadic ALS 61 NF1 61 atypical hyperplasia 61 IUGR 61 fetal aneuploidy 61 genetic alterations 61 chromosomally abnormal 61 spontaneous mutations 61 genetic variations 61 premature menopause 61 mtDNA mutations 61 chromosomal defects 61 monozygotic twins 61 BRCA mutations 61 germline mutations 61 IgA deficiency 61 Klinefelter syndrome 61 APOE e4 60 dizygotic twins 60 hereditary breast cancer 60 malformations 60 CNVs 60 de novo mutations 60 epigenetic changes 60 HbF 60 chromosomal anomaly 60 p# mutations 60 genetic defect 60 BRCA1 gene 60 BRCA mutation 60 LQTS 60 premature ovarian 60 genetic variants 60 susceptibility genes 60 atypia 59 genetic disorders 59 lung adenocarcinoma 59 fetal chromosomal 59 fetal malformations 59 gene mutation 59 hamartomas 59 adenomatous polyps 59 genes BRCA1 59 BRCA1 59 HNPCC 59 MSH2 59 chromosomal 59 gene expression patterns 59 chromosomal disorder 59 pathogenic mutations 59 CGG repeats 59 pre eclampsia 59 recurrent miscarriage 59 BRCA2 mutation 59 BRCA2 mutations 59 polycystic ovary syndrome PCOS 59 methylation 59 abnormal growths 59 polycystic ovary syndrome 59 colorectal cancer CRC 59 mutated genes 59 array CGH 59 benign growths 59 mutation 59 medulloblastomas 59 causative gene 59 mutated gene 59 karyotyping 59 chromosomal abnormality 59 penetrance 59 colorectal neoplasia 58 colorectal polyps 58 ovarian cancers 58 autistic traits 58 #q#.# [001] 58 lobular breast cancer 58 pre eclamptic 58 PTEN mutations 58 neurofibromas 58 familial pancreatic cancer 58 Cytogenetic 58 congenital disorders 58 genetic mutation 58 aneuploid 58 MLH1 58 fetal abnormalities 58 BRCA2 58 mitochondrial diseases 58 neuroblastomas 58 BRCA2 gene mutations 58 breast cancer genes BRCA1 58 imprinted genes 58 Trisomy 58 methylation markers 58 benign lesions 58 BRCA2 carriers 58 mutant genes 58 chromosomal rearrangement 58 male infertility 58 NF2 58 FMR1 gene 58 preeclampsia 58 precursor lesions 58 MCAD deficiency 58 thrombophilia 58 mammary cancers 58 genomic rearrangements 58 adenoma 58 mutated BRCA1 58 ependymomas 58 normal karyotype 57 mitochondrial mutations 57 sCJD 57 primary biliary cirrhosis 57 molar pregnancy 57 Beckwith Wiedemann syndrome 57 karyotype 57 G#S mutation 57 bowel cancers 57 mammographic density 57 hypermethylation 57 DNA methylation 57 cancers 57 clefting 57 IKZF1 57 chorionic villi 57 ovarian hyperstimulation 57 genetic polymorphisms 57 Meckel Gruber 57 genetic markers 57 testicular germ cell 57 Rh incompatibility 57 chromosomally normal 57 MCADD 57 NGAL 57 egg follicles 57 chromosomal translocations 57 holoprosencephaly 57 Apert syndrome 57 breast carcinomas 57 poorer prognosis 57 Fanconi anemia 57 tumors 57 #q#.# [002] 57 BCL#A 57 chorionic villus sampling 57 BRAF gene 57 familial adenomatous polyposis 57 chromosome rearrangements 57 fetal chromosomal abnormalities 57 untreated celiac disease 57 NAFLD 57 Li Fraumeni syndrome 57 DNA methylation patterns 57 SNPs 57 epigenetic alterations 57 aneuploidy screening 57 chromosomal deletions 57 TCF#L# gene 57 susceptibility gene 57 basal cell nevus syndrome 57 microRNA expression 57 haematopoietic 57 FXTAS 57 p# mutation 57 PALB2 57 malformation 57 advanced adenomas 57 diagnosed prenatally 57 prenatally diagnosed 57 NNRTI resistance 57 lobular cancer 57 subclinical hyperthyroidism 57 chromosomal rearrangements 57 KRAS oncogene 57 subfertility 56 subclinical atherosclerosis 56 microsatellite instability 56 amniocentesis 56 nonmelanoma skin cancers 56 benign breast 56 renal cell carcinomas 56 persistent pulmonary hypertension 56 preimplantation genetic diagnosis 56 uterine cancers 56 IVF ICSI 56 rs# [002] 56 microvascular disease 56 LRRK2 gene 56 ALK mutations 56 APOE ε4 56 FTLD 56 GISTs 56 malignancies 56 genetic susceptibility 56 CHD7 56 varicoceles 56 brain lesions 56 Chromosomal abnormalities 56 epigenetic markers 56 metastases 56 anovulation 56 varicocele 56 osteosarcomas 56 rs# [001] 56 progranulin 56 FMR1 56 breast cancers 56 chlamydial infection 56 heterozygous 56 homozygosity 56 meningiomas 56 adenocarcinomas 56 chromosomal imbalance 56 embryo biopsy 56 thyroglobulin 56 genomewide 56 intestinal polyps 56 Clusterin 56 autoantibodies 56 precancerous lesions 56 neurodevelopmental disorders 56 dizygotic 56 BRCA2 mutation carriers 56 nucleotide substitutions 56 APOE gene 56 Genetic variants 56 thyroid nodules 56 vitro maturation 56 heterozygotes 56 myeloperoxidase 56 pilocytic astrocytomas 56 spontaneous mutation 56 gene variant 56 Hashimoto thyroiditis 56 FGFR2 gene 56 mammary cells 56 postnatally 56 Peutz Jeghers syndrome 56 gene amplification 56 BARD1 56 APOE4 56 neoplasms 56 monogenic 56 prenatal diagnosis 56 CIN3 56 atherosclerotic lesions 56 ductal breast cancer 56 adenomas 56 ovarian hormones 56 ovarian 56 FGFR2 56 autosomal 56 leiomyomas 56 BRCA genes 55 missense mutations 55 aneuploid cells 55 monozygotic 55 colorectal tumors 55 bronchopulmonary dysplasia 55 alleles 55 thyroid cancers 55 genetic variant 55 advanced neoplasia 55 intrauterine infection 55 somatic mutation 55 blastomeres 55 neurodevelopmental disorder 55 multiple gestations 55 primary ovarian insufficiency 55 karyotypes 55 ectopic 55 mitochondrial disorders 55 malignant transformation 55 GBA mutations 55 testicular cancers 55 polycystic ovaries 55 teratoma 55 DNA rearrangements 55 endometrial carcinoma 55 OGG1 55 amyloid deposition 55 TMEM#B 55 testicular tumors 55 mammary tumors 55 colonic polyps 55 molecular abnormalities 55 transfusion syndrome 55 GSTP1 55 genomic instability 55 myopathies 55 CHEK2 55 hereditary diseases 55 SORL1 55 PARP inhibition 55 urine cytology 55 thyrotropin levels 55 bowel polyps 55 cystatin C 55 LIS1 55 achromatopsia 55 polymorphisms 55 CIN2 + 55 #q# [001] 55 hydrops 55 placenta praevia 55 prostate cancers 55 heterotaxy 55 diagnostic biomarker 55 CFTR gene 55 chorioamnionitis 55 ependymoma 55 single nucleotide polymorphism 55 thyroid hormone levels 55 AAT deficiency 55 maternally inherited 55 microcephalin 55 Amniocentesis 55 ductal cancer 55 diagnosis PGD 55 ectopic pregnancies 55 bladder cancers 55 TTTS 55 preterm delivery 55 JAK mutations 55 thyroid dysfunction 55 advanced adenoma 55 shortened telomeres 55 metabolic abnormalities 55 TP# mutations 55 cryptorchidism 55 BRCA1 mutation carriers 55 chromosomal aberration 55 axillary lymph nodes 55 monozygotic twin 55 genetic variation 55 genetic variants associated 55 MGUS 55 chromosome aberrations 55 Cowden syndrome 55 ADPKD 55 MTHFR 55 BRCA2 gene mutation 55 prion infection 55 genetic imprinting 55 defective gene 55 hemangiomas 55 PTEN gene 55 BRCA1 mutation 55 gene rearrangements 55 precancerous tumors 55 gastric carcinoma 55 lung tumors 55 IVF pregnancies 55 HER2 overexpression 55 splice junctions 55 cervical abnormalities 55 benign polyps 55 neurodevelopmental 55 epigenetic modification 55 cystic fibrosis muscular dystrophy 55 pre cancerous lesions 55 BRCA gene mutation 55 autism susceptibility genes 55 MLL2 55 telomere lengths 55 prostate cancer CaP 55 polycystic ovarian syndrome PCOS 54 TYMS 54 mitochondrial DNA mtDNA 54 VHL gene 54 phthalate exposure 54 hyperplasia 54 neuro developmental 54 PCa 54 genes predisposing 54 PTPN# 54 lobular carcinoma 54 activating mutations 54 catheter angiography 54 HMGA2 54 subclinical hypothyroidism 54 breast tumors 54 prenatal ultrasound 54 Leydig cell 54 biopsied embryos 54 Rb gene 54 abnormal methylation 54 micro RNAs 54 gestational diabetes 54 CNTNAP2 gene 54 unexplained mental retardation 54 GBM tumors 54 pheochromocytomas 54 MSMB 54 colon cancers 54 pyloric stenosis 54 #q# deletion 54 placenta accreta 54 motor neuron degeneration 54 gene BRCA2 54 subclinical 54 BRIP1 54 MECP2 gene 54 mesotheliomas 54 breast lesions 54 EGFR mutations 54 mtDNA 54 malignant polyps 54 POAG 54 TP# mutation 54 singleton pregnancy 54 breast carcinoma 54 ASDs 54 Joubert syndromes 54 kidney cysts 54 beta thalassemia 54 BRAC2 54 GSTT1 54 intracytoplasmic sperm injection 54 deleterious mutation 54 HGPIN 54 anal cancers 54 VUR 54 Aneuploidy 54 miRNA genes 54 Velculescu 54 CYP#D# gene 54 p tau 54 seminomas 54 nonhereditary 54 prognostic markers 54 TCF#L# 54 bladder tumors 54 miRNA expression 54 BRCA gene mutations 54 phenotypes 54 autosomal recessive 54 invasive carcinoma 54 CYP#B# 54 #q#.# deletion syndrome 54 causal variants 54 generalized vitiligo 54 ZNF# 54 Genetic mutations 54 cytogenetic 54 hamartoma 54 ORMDL3 54 de ath 54 gestational diabetes mellitus 54 CMV infection 54 dopamine transporter gene 54 leukaemias 54 leiomyoma 54 elevated CRP 54 atherosclerotic lesion 54 Metastases 54 EoE 54 Genetic predisposition 54 hereditary predisposition 54 basal cell carcinomas 54 G6PD deficiency 54 HLA genes 54 BRCA carriers 54 Chromosomal 54 JAK2 mutation 54 shorter telomeres 54 carcinomas 54 aberrant methylation 54 #q deletion 54 BRCA1 BRCA2 54 tumor recurrence 54 genital tract infections 54 nerve degeneration 54 undescended testicles 54 APOL1 54 nevi 54 infertility 54 filaggrin 54 spinocerebellar ataxia 54 ductal lobular 54 distant metastasis 53 B7 H3 53 endostatin 53 metastatic lesions 53 UGT#A# * 53 colon tumors 53 pre cancerous polyps 53 endometrial hyperplasia 53 autosomal dominant inheritance 53 embryonal 53 ductal 53 phenylketonuria 53 CCR3 53 MYH9 gene 53 precancerous polyps 53 nonsense mutations 53 epithelial tumors 53 HNSCC 53 germ cells 53 homozygous 53 CDH1 53 toxoplasmosis 53 apolipoprotein E gene 53 thyroid tumors 53 tumor suppressor gene 53 IGF2 53 premenopausal breast cancer 53 chromosome #q#.# [001] 53 prostate pancreatic 53 uveal melanoma 53 FISH fluorescence 53 Retinopathy 53 Down syndrome 53 luminal cells 53 pre malignant lesions 53 allelic 53 LRRK2 mutations 53 MYCN amplification 53 prostate abnormalities 53 polyhydramnios 53 infarcts 53 breast endometrial 53 p#INK#a 53 Adenomas 53 anencephaly 53 premalignant lesions 53 CHDs 53 epigenetic 53 gene expression profiles 53 ambiguous genitalia 53 T1DM 53 abnormal Pap test 53 oropharyngeal cancer 53 MC1R 53 impair fertility 53 dopamine receptor gene 53 denser breasts 53 TMPRSS2 ERG 53 TACI mutations 53 RhD 53 sonographic diagnosis 53 lung adenocarcinomas 53 cytologic 53 folate deficiency 53 cervical lesions 53 genomic imprinting 53 IDH1 53 neoplasia 53 heritable 53 mucinous 53 tumor suppressor genes 53 methylation patterns 53 bronchopulmonary dysplasia BPD 53 basal cell carcinoma BCC 53 specific antigen 53 triplet pregnancies 53 germline mutation 53 penile cancers 53 polycystic ovarian syndrome 53 missense mutation 53 estrogen receptor negative 53 TGFBR1 * 6A 53 infertility miscarriage 53 NR#A# gene 53 BRCA gene 53 galactosemia 53 clusterin 53 micrometastases 53 SHANK3 53 recessive genes 53 medulloblastoma 53 biochemical abnormalities 53 vimentin 53 mRNA expression 53 herpesviruses 53 biochemical markers 53 genotoxic stress 53 microalbuminuria 53 genetic 53 gene variation 53 Li Fraumeni 53 ovarian function 53 proband 53 methylated DNA 53 abnormality 53 Hurler syndrome 53 mammographically 53 ovarian dysfunction 53 proto oncogene 53 genes 53 Male infertility 53 carotid stenosis 53 SUVmax 53 white matter hyperintensities 53 genetic predisposition 53 frequently benign tumor 53 extracolonic findings 53 immunohistochemical 53 cervical carcinoma 53 LRAT 53 spontaneously regress 53 STAT4 53 ERBB2 53 HER2 expression 53 HER2 positive tumors 53 K ras mutations 53 myelomeningocele 53 lung nodules 53 hyperinsulinism 53 Kabuki syndrome 53 PON1 53 PALB2 gene 53 BRCA mutation carriers 53 hereditary disorders 53 curable cancers 53 miRNAs 53 chromosomes 53 sFlt 1 53 promoter hypermethylation 53 chromosome #q# [001] 53 gene fusions 53 intracytoplasmic sperm injection ICSI 53 deCODE BreastCancer TM 53 HGPS 53 Angelman syndrome 53 placental 53 PITX2 53 recessive trait 53 cervical intraepithelial neoplasia 53 Uterine fibroids 53 ApoE4 gene 53 Folic acid deficiency 53 exome sequencing 53 HER2 gene 53 gene deletions 53 polymorphism 53 Preimplantation genetic diagnosis 53 congenital defects 53 mitochondrial defects 53 Genetic variations 53 allele frequencies 53 antral follicles 53 prepubertal 53 chromosomal regions 53 stratifying patients 53 MLL gene 53 congenital adrenal hyperplasia CAH 53 segmental duplications 53 SHBG levels 53 ovulation induction 53 incidentalomas 53 micronuclei 53 biomarkers 53 fertilized egg splits 53 hyperplastic 53 EGFR gene 53 TMPRSS2 ERG fusion 53 SNHL 53 genomic variants 53 blocked fallopian tubes 53 dyskeratosis congenita 53 phenotypic variation 52 breast cancer susceptibility genes 52 cytogenic 52 behavioral disinhibition 52 malignant tumors 52 macrosomia 52 genomic deletions 52 pAkt 52 premalignant 52 elevated triglyceride levels 52 brain malformation 52 lipid abnormalities 52 pancreatic cysts 52 Malignant tumors 52 hypospadias 52 gonadal hormones 52 MeCP2 gene 52 neoplasm 52 chromosomal mutations 52 RUNX3 52 genomic alterations 52 promoter methylation 52 DiGeorge syndrome 52 5q 52 neurological abnormalities 52 singleton pregnancies 52 astrocytomas 52 Genetic variation 52 loci 52 FMRP protein 52 fibroids endometriosis 52 GSTM1 52 elevated depressive symptoms 52 maternal serum 52 cataract formation 52 facial clefts 52 nestin 52 teratomas 52 BRCA 52 hematopoietic cancers 52 genetic aberrations 52 skeletal metastases 52 precancer 52 uterine tumors 52 affective psychoses 52 autosomal dominant disorder 52 TP# gene 52 adnexal mass 52 TOP2A 52 breast cancer metastasis 52 ectodermal dysplasia 52 noncoding RNAs 52 pancreatic endocrine 52 IDH1 mutation 52 mitochondrial DNA 52 abnormal cytology 52 myotonic dystrophy 52 preeclamptic 52 indels 52 lobular carcinomas 52 VEGF expression 52 SOD1 gene 52 causative genes 52 transgene expression 52 GATA4 52 ERCC1 52 fetal anomalies 52 hereditary nonpolyposis colorectal cancer 52 gene expression 52 lung lesions 52 meningioma 52 SLNB 52 prion disease 52 troponin T 52 Telomere length 52 postmenopausal breast cancer 52 assisted reproduction 52 microRNA molecules 52 autoimmune thyroid 52 ABCB1 52 mutant protein 52 hereditary hemochromatosis 52 PGD PGS 52 born preterm 52 mutant huntingtin protein 52 HLA antigens 52 Folate deficiency 52 inherited predisposition 52 lobular 52 SMN2 52 irregular menstrual cycles 52 ovarian cysts 52 autosomal dominant 52 Wilms tumor 52 parous women 52 Inhibin B 52 causative mutation 52 coding genes 52 folate metabolism 52 IVF embryos 52 Dravet syndrome 52 connexin 52 Jhdm2a 52 LKB1 52 microbleeds 52 deletion 5q 52 APOE 52 salpingo oophorectomy 52 nonmelanoma skin cancer 52 grade cervical intraepithelial 52 #p#.# [001] 52 Abnormalities 52 lissencephaly 52 pre cancerous 52 albuminuria 52 ectopic pregnancy 52 heterozygosity 52 renal scarring 52 hypermethylated 52 BCR ABL mutations 52 malignant lesions 52 hematopoietic malignancies 52 TT genotype 52 ductal carcinomas 52 choriocarcinoma 52 oophorectomy 52 nucleotide variations 52 pre cancerous growths 52 APOE e4 gene 52 growth restriction IUGR 52 melanomas 52 cell carcinomas 52 ovulatory cycles 52 virulence genes 52 pathophysiologic 52 oral clefts 52 paternal discrepancy 52 nulliparous 52 prolactin 52 hydroxyvitamin D levels 52 telomere length 52 mutant alleles 52 diaphragmatic hernia 52 PIK3CA 52 genetic alteration 52 HLA DRB1 52 polycystic kidneys 52 metabolomic profiles 52 testicular biopsy 52 BRCA2 breast cancer 52 invasive cervical cancer 52 CDKN2A 52 KCNH2 52 C#Y 52 PGD 52 beta1 integrin 52 narcolepsy cataplexy 52 proximal colon 52 X chromosome 52 CNTNAP2 52 BRAF mutations 52 structural abnormalities 52 homozygotes 52 KIF6 gene 52 azoospermia 52 pituitary tumors 52 Prenatal diagnosis 52 CYP#C# [002] 52 RhD negative 52 iPSCs 52 genetic makeups 52 lymph node metastases 52 non coding RNA 52 Heavy menstrual bleeding 52 epigenetic silencing 52 neurologic complications 52 skeletal malformations 52 genetic loci 52 pCR 52 molecular biomarkers 52 familial hypercholesterolemia 52 Cockayne syndrome 52 apoE 52 lesions 52 noncancerous 52 PSADT 52 colorectal neoplasms 52 congenital hypothyroidism 52 implantation genetic 52 dysplasia 52 Mitochondrial diseases 52 pelvic inflammatory disease 52 exfoliation glaucoma 52 node metastases 52 liver fibrosis 52 retinopathy 52 SPINK1 52 carcinoid 52 liver metastasis 52 PDGFRA 52 chromosome translocations 52 mutant allele 52 ovarian malignancy 52 metastatic disease 52 rs# [003] 52 cardiac progenitor cells 52 uterine ovarian 52 gastrointestinal GI cancers 52 phthalate syndrome 52 developmental disorders 52 CYP#D# 52 congenital CMV 52 ovarian hyperstimulation syndrome OHSS 52 sentinel nodes 52 systemic scleroderma 51 Fragile X gene 51 primordial germ cells 51 carotid artery thickness 51 precancerous cervical 51 WT1 51 overdiagnosis 51 CIN2 51 abnormal proteins 51 MetS 51 BRAF mutation 51 Premature Ovarian Failure 51 ovules 51 epididymitis 51 glioma tumors 51 endothelial dysfunction 51 CALHM1 51 KRAS mutations 51 TCF4 51 intraventricular hemorrhage 51 glucose intolerance 51 overexpress 51 prostate adenocarcinoma 51 cyclin E 51 Preimplantation Genetic Diagnosis PGD 51 unneeded biopsies 51 hypopituitarism 51 rs# [004] 51 Kufs disease 51 Brugada syndrome 51 postoperative delirium 51 cell adhesion molecule 51 KIT mutations 51 genital abnormalities 51 endometrial 51 periodontitis 51 cause cardiac channelopathies 51 CagA 51 precancerous polyp 51 conceiving naturally 51 RET PTC rearrangements 51 sequence homology 51 Polycystic Ovarian Syndrome PCOS 51 SLC#A# [002] 51 GIST tumors 51 microchimerism 51 blastomere 51 HPV infections 51 follicle stimulating hormone 51 gestational hypertension 51 stillbirth 51 MTHFR gene 51 nuchal translucency 51 ipRGCs 51 Pten 51 MC4R gene 51 proteinuria 51 hydronephrosis 51 lymph node metastasis 51 testosterone secretion 51 folate intake 51 NPM1 51 hemolytic disease 51 thyroid hormone deficiency 51 sarcosine 51 amniotic cells 51 malignancy 51 Colon polyps 51 NPY gene 51 dyscalculia 51 esophageal cancers 51 insulin resistance 51 XMRV infection 51 neoplastic 51 gene APOE 51 Sjögren syndrome 51 mRNA transcripts 51 arterial calcification 51 Hemangiomas 51 endoglin 51 Hurthle cell 51 malignant prostate 51 phthalate metabolites

Back to home page